TITLE

The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial

AUTHOR(S)
Welschen, Laura M. C.; Bot, Sandra D. M.; Dekker, Jacqueline M.; Timmermans, Daniëlle R. M.; van der Weijden, Trudy; Nijpels, Giel
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10, p457
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Patients with type 2 diabetes mellitus (T2DM) have an increased risk to develop severe diabetes related complications, especially cardiovascular disease (CVD). The risk to develop CVD can be estimated by means of risk formulas. However, patients have difficulties to understand the outcomes of these formulas. As a result, they may not recognize the importance of changing lifestyle and taking medication in time. Therefore, it is important to develop risk communication methods, that will improve the patients' understanding of risks associated with having diabetes, which enables them to make informed choices about their diabetes care. The aim of this study is to investigate the effects of an intervention focussed on the communication of the absolute 10-year risk to develop CVD on risk perception, attitude and intention to change lifestyle behaviour in patients with T2DM. The conceptual framework of the intervention is based on the Theory of Planned Behaviour and the Self-regulation Theory. Methods: A randomised controlled trial will be performed in the Diabetes Care System West-Friesland (DCS), a managed care system. Newly referred T2DM patients of the DCS, younger than 75 years will be eligible for the study. The intervention group will be exposed to risk communication on CVD, on top of standard managed care of the DCS. This intervention consists of a simple explanation on the causes and consequences of CVD, and possibilities for prevention. The probabilities of CVD in 10 year will be explained in natural frequencies and visualised by a population diagram. The control group will receive standard managed care. The primary outcome is appropriateness of risk perception. Secondary outcomes are attitude and intention to change lifestyle behaviour and illness perception. Differences between baseline and follow-up (2 and 12 weeks) between groups will be analysed according to the intention-to-treat principle. The study was powered on 120 patients in each group. Discussion: This innovative risk communication method based on two behavioural theories might improve patient's appropriateness of risk perception and attitude concerning lifestyle change. With a better understanding of their CVD risk, patients will be able to make informed choices concerning diabetes care. Trail registration: The trial is registered as NTR1556 in the Dutch Trial Register.
ACCESSION #
53412628

 

Related Articles

  • CV Event Risk Lower with Metformin. STEIN, JILL // Renal & Urology News;Sep2011, Vol. 10 Issue 9, p1 

    The article reports on the findings of a study conducted by Alex Z. Fu and colleagues which reveals that older patients with type 2 diabetes have a significantly lower likelihood of experiencing a cardiovascular (CV) event within two years if they start a treatment with metformin.

  • Attenuating Cardiovascular Risk Factors in Patients with Type 2 Diabetes.  // American Family Physician;12/15/2000, Vol. 62 Issue 12, p2633 

    Patients with type 2 diabetes (formerly known as non-insulin-resistant diabetes) have a significantly increased risk of developing cardiovascular disease. Once clinical cardiovascular disease develops, these patients have a poorer prognosis than normoglycemic patients. By inducing endothelial...

  • Gliptins neither benefit nor harm T2DM cardiovascular outcomes.  // Reactions Weekly;9/28/2013, Issue 1471, p4 

    The article discusses the ineffectiveness of antihyperglycaemics saxagliptin and alogliptin in cardiovascular outcomes in type 2 diabetic patients.

  • Saxagliptin does not increase risk of CV events.  // Reactions Weekly;Nov2015, Vol. 1578 Issue 1, p10 

    The article presents a study which shows that saxagliptin does not increase cardiovascular (CV) risk events in patients having type 2 diabetes mellitus irrespective of glycaemic control.

  • Basic Science -- Diabetes.  // Current Medical Literature: Diabetes;2008, Vol. 25 Issue 1, p17 

    This article discusses several studies done about diabetes, published in different journals. These include CA 19-9 levels in patients with type 2 diabetes mellitus, aerobic fitness and hand grip strength in type 1 diabetes, and attenuation of amydgala and frontal cortical responses to low blood...

  • Evaluation of cognitive functions and the related factors in 50-80 year type 2 diabetic subjects. Temizel, Mustafa; Mert, Meral; Yanar, Hakan; Arman, Yucel; Arslan, Kadem; Alakus, Feride; Velioglu, Ebru // International Journal of Diabetes in Developing Countries;Jun2013, Vol. 33 Issue 2, p71 

    To study cognitive functions in 50-80 year aged type 2 diabetic patients. Cognitive performance was evaluated through a mini mental test (MMT) in 131 patients between 50 and 80 years (100 type 2 diabetics and 31 non-diabetics). Relation analysis were carried out for different parameters. Scores...

  • Quality of Life and Adjustment among Type II Diabetes Patients With and Without Lower Limb Amputation. Zaidi, Ghazal; Zafar, Nida; Noor-ul-Huda; Zubair, Raesa; Farooq, Sehrish; Kausar, Rukhsana // Journal of Behavioural Sciences;2013 Special issue, Vol. 23 Issue 3, p72 

    The article focuses on a study conducted by the authors related to how lower limb amputation affects type II diabetes patients's quality of life and adjustments they have to make. It states that those who were not amputated had better quality of life as compared to those who were. It highlights...

  • Comparison of effect of metformin in combination with glimepiride and glibenclamide on glycaemic control in patient with type 2 diabetes mellitus. Shimpi, R. D.; Patil, P. H.; Kuchake, V. G.; Ingle, P. V.; Surana, S. J.; Dighore, P. N. // International Journal of PharmTech Research;Jan2009, Vol. 1 Issue 1, p50 

    The aim of the present study is to compare the effect of metformin in combination with Glimepiride and Glibenclamide In patient with type 2 Diabetes Mellitus. Subjects and method: This is an open-label, randomized study carried out to study the effect of metformin when it is given in combination...

  • Depression in Patients with Type II Diabetes: Case study at Diabetic Outpatient Clinic, in Samut Prakan. Thongsai, Soontareeporn; Watanabenjasopa, Suntaree; Youjaiyen, Malinee // Global Journal of Health Science;2014, Vol. 6 Issue 1, p127 

    This descriptive research studied the depression level of patients with diabetes type II at diabetic clinics in Samut Prakarn, and, identified the causes of severe depression in patients with type 2. There were 209 participants enrolled in the study. The samples were selected by opportunistic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics